Literature DB >> 1729275

Gold-specific T cells in rheumatoid arthritis patients treated with gold.

P Romagnoli1, G A Spinas, F Sinigaglia.   

Abstract

Gold-specific T lymphocyte clones were isolated from a patient with rheumatoid arthritis who developed delayed type hypersensitivity reactions to gold. All of the isolated T cell clones required histocompatible antigen presenting cells as well as gold for induction of proliferation. Using a panel of HLA-homozygous Epstein Barr virus-transformed B (EBV-B) cells and anti-HLA antibodies, the clones were shown to recognize gold in the context of DR1 molecules. Gold recognition did not require active antigen processing since specific proliferation was not affected by glutaraldehyde fixation of the DR1 homozygous antigen presenting cells. Furthermore, we could show that gold salts inhibited peptide-induced responses of a peptide-specific T cell clone. In addition to providing evidence for gold-specific T cells in gold-treated RA patients exhibiting delayed type hypersensitivity responses, these data suggest that gold can alter MHC-peptide complexes. The latter observation may in part explain the mechanism/s responsible for both the therapeutic and the toxic effects of gold.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729275      PMCID: PMC442843          DOI: 10.1172/JCI115569

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Selection of T cell epitopes and vaccine engineering.

Authors:  F Sinigaglia; P Romagnoli; M Guttinger; B Takacs; J R Pink
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Present status of gold therapy for rheumatoid arthritis.

Authors:  R H FREYBERG
Journal:  J Am Med Assoc       Date:  1950-06-03

Review 3.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

4.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

5.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

6.  Vaccine T-cell epitope selection by a peptide competition assay.

Authors:  J Kilgus; P Romagnoli; M Guttinger; D Stuber; L Adorini; F Sinigaglia
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

7.  A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.

Authors:  F Sinigaglia; M Guttinger; J Kilgus; D M Doran; H Matile; H Etlinger; A Trzeciak; D Gillessen; J R Pink
Journal:  Nature       Date:  1988 Dec 22-29       Impact factor: 49.962

8.  Immunological characterization of lymphocytes in synovial fluid from patients with rheumatoid arthritis.

Authors:  S S Froland; J B Natvig; G Husby
Journal:  Scand J Immunol       Date:  1973       Impact factor: 3.487

9.  Nonpolymorphic regions of p190, a protein of the Plasmodium falciparum erythrocytic stage, contain both T and B cell epitopes.

Authors:  F Sinigaglia; B Takacs; H Jacot; H Matile; J R Pink; A Crisanti; H Bujard
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

10.  Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein.

Authors:  F Sinigaglia; M Guttinger; D Gillessen; D M Doran; B Takacs; H Matile; A Trzeciak; J R Pink
Journal:  Eur J Immunol       Date:  1988-04       Impact factor: 5.532

View more
  9 in total

1.  Inhibition of interleukin-12 production by auranofin, an anti-rheumatic gold compound, deviates CD4(+) T cells from the Th1 to the Th2 pathway.

Authors:  T S Kim; B Y Kang; M H Lee; Y K Choe; S Y Hwang
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

2.  Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones.

Authors:  B Schnyder; D Mauri-Hellweg; M Zanni; F Bettens; W J Pichler
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 3.  Understanding the complexity and malleability of T-cell recognition.

Authors:  John J Miles; James McCluskey; Jamie Rossjohn; Stephanie Gras
Journal:  Immunol Cell Biol       Date:  2015-01-13       Impact factor: 5.126

Review 4.  Heparin-induced thrombocytopenia: molecular pathogenesis.

Authors:  Seon Ho Lee; Chao Yan Liu; Gian PaoloVisentin
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 5.  Drug-induced thrombocytopenia.

Authors:  Gian Paolo Visentin; Chao Yan Liu
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

6.  Silicone-specific blood lymphocyte response in women with silicone breast implants.

Authors:  E A Ojo-Amaize; V Conte; H C Lin; R F Brucker; M S Agopian; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

Review 7.  Major histocompatibility complex genomics and human disease.

Authors:  John Trowsdale; Julian C Knight
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-15       Impact factor: 8.929

Review 8.  Metals and kidney autoimmunity.

Authors:  P E Bigazzi
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

Review 9.  Speciation in Metal Toxicity and Metal-Based Therapeutics.

Authors:  Douglas M Templeton
Journal:  Toxics       Date:  2015-04-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.